![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Contained and sterile transfer solutions expert, ChargePoint Technology announces new, single use additions to its portfolio; the ChargePoint® Single Use Passive (SUP) and ChargeBag® PE-S with new HiPure ULP7 PE film.
Together, the two products form a high performance, single use package for the contained and sterile transfer of pharmaceutical powders between manufacturing process steps or even facilities.
The ChargePoint SUP is a disposable version of the passive mating half of the industry renowned ChargePoint SBV (Split Butterfly Valve) technology, which forms a complete hybrid system to ensure users can take advantage of the benefits of disposable technology without compromising performance. This also ensures the new single use products are compatible with existing ChargePoint SBV systems in the field.
Constructed completely of FDA and USP Class VI compliant materials, the SUP is both lightweight and cost effective, delivering containment and sterility assurance performance whilst eliminating the time and cost associated with cleaning, maintenance and validation.
The new ChargeBag® PE-S is a flexible, single use product container for the handling, storage and transfer of bio-pharmaceutical powders.
Manufactured from HiPure ULP7 a new proprietary film, developed exclusively by ChargePoint Technology, and compliance tested to meet the demands of even the most critical aseptic processing environments, the solution enables extremely high levels of integrity with optimised purity and robustness characteristics.
Chris Eccles, CEO, ChargePoint Technology says, “As pharmaceutical manufacturing environments evolve, we will continue to push the boundaries of innovation and remain at the forefront of contained transfer advancements, responding to the challenges of today and tomorrow. We are excited to take our first steps into the realm of single use technology as we look for new ways to deliver compliant, flexible solutions to our customers.”
He continues: “Whilst traditional single use technologies claim to deliver the same level of performance as some of the more robust solutions, the reality is that this is not the case over repeated operations. ChargePoint’s hybrid solution delivers repeatable performance as well as offering several advantages to pharmaceutical manufacturers. The convenience and control benefits associated with pre-validated, ready to use solutions, that are easily integrated and perform to the highest level of containment and sterility assurance, are invaluable for our customers”.
In line with the next generation of transfer solutions, ChargePoint Technology is also introducing its latest update of the ChargePoint SBV system, Series 3. Featuring a new and improved locking mechanism with intuitive mechanical interlocks the system is operator friendly and reduces risk of part wear. On automatic versions, quick release actuators and sensor sockets ensure fast set up and changeover whilst improved access to the main disc seal makes maintenance steps more convenient than ever before.
For more information on the new disposable solutions, please visit ChargePoint Technology at Interphex NY on 2nd April at booth #3033. Alternatively, please visit http://www.thechargepoint.com/disposable
About ChargePoint Technology
ChargePoint Technology is the trusted specialist for safe and reliable contained and sterile transfer solutions in the pharmaceutical, biotech, chemical and other process industries. Its client portfolio includes some of the top 25 pharmaceutical companies and reaches into North America, UK, Europe, China and India, amongst others.
ChargePoint Technology manufactures its cutting-edge devices in its purpose-built facility in Liverpool, UK, employs more than 80 employees across the globe and secured a multi-million pound investment from LDC, part of Lloyds Banking Group in January 2017, to meet the increase in global demand for its products and solutions.
The product range includes:
- Containment solutions – ChargePoint’s containment solutions provide a reduced risk of cross contamination via closed transfers, ensure the safety of your personnel and provide a dust free environment when processing toxic powders and high potent APIs.
- Sterility assurance solutions – ChargePoint’s product range for sterility assurance has been developed to perform aseptic transfers that maintain critical area integrity, reduce risk of contamination via closed transfers and meet GMP and product quality requirements.
- Single use solutions – ChargePoint’s single use solutions provide the containment and sterility assurance required for handling high potent ingredients and chemicals with the cost effectiveness of disposable technology.
